Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Project Updates and Milestones news
(page 10)
20 May 2026
BASF Coatings named GM 2025 Supplier of the Year
Named 2025 Supplier of the Year at a 34th annual Austin event for outstanding performance, innovation and partnership; one of 103 global awardees; readies for Carlyle ownership transition in Q2 2026.
20 May 2026
Gasunie opens first 32-km section of Dutch hydrogen network
King and minister inaugurated the first pipeline segment. Network planned ~1,200 km via repurposed gas pipelines, linking Dutch industry to Germany and Belgium; first plant now connected.
20 May 2026
Vattenfall opens 139 MW Bruzaholm wind farm
Park in Eksjö will produce ~460 GWh/yr; ~50% allocated to Volvo under a long-term PPA. Features 38 MW/38 MWh battery, local financial support and biodiversity measures
20 May 2026
Covestro opens TPU Application Development Center in Guangzhou, China
New TPU AD Center links Zhuhai production and Changhua R&D, offering extrusion/injection simulation, compounding, color and pilot film lines to speed APAC solutions
20 May 2026
bp signs three PSCs in Indonesia
Signed three PSCs in Indonesia: Bintuni and Drawa near Tangguh LNG (potential short‑cycle development) and Barong in East Java, raising participation to 11 blocks; part of 2025 bidding round.
20 May 2026
MAIRE wins ~€1.3bn in new awards, including large E&C project and urea plant licensing & PDP
Awards cover projects across Asia, Europe and the Americas under IE&CS and STS units; Tecnimont and KT to execute onshore and refinery works; further details pending formalities.
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
19 May 2026
RWE expands Hambach with 16.5 MW solar park and 80 MWh battery
At Hambach's Manheimer Bucht, 25,300 panels across ~20 football pitches will power ~5,000 homes. Battery construction starts this summer to support grid stability; municipalities may join.
19 May 2026
Novo Nordisk: Semaglutide shows hepatic safety and efficacy in MASH
ESSENCE subgroup analyses (menopause, Japanese) and real-world data show broad benefit across populations, highlight severe underdiagnosis, reduced quality of life and rising healthcare costs
19 May 2026
Repono launches 202 MW BESS in Romania with Gunvor and enspired
202 MW/404 MWh BESS in Argeș, Romania — one of SE Europe's largest. Project will be commercially managed and optimized for multiple revenue streams; COD targeted Q2 2027 pending financing.
19 May 2026
Statkraft to invest NOK 80bn in Norwegian hydropower over 10 years
Half for major maintenance; rest for upgrades, new capacity and wind repowering. Nationwide dam reinforcements, turbine and tunnel refurbishments; projects need permits and profitability
18 May 2026
Teijin Frontier expands OCTAIR™ insulation fiber capacity at Matsuyama Plant
New equipment will boost OCTAIR™ output starting March 2027 to meet demand for down alternatives, targeting about 1,000 t/yr by 2030.
18 May 2026
Boehringer Ingelheim's JASCAYD (nerandomilast) approved in Japan for IPF and PPF
First oral PDE4B inhibitor shows slowed FVC decline in FIBRONEER Phase III; pooled analysis showed 59% nominal death reduction. Common AE: diarrhea; EU/UK reviews ongoing.
18 May 2026
Genentech to present ASCO 2026 data on giredestrant in early ER+ breast cancer
Presents data on nine drugs across 15+ indications: breast‑cancer first‑line/post‑progression analyses, HER2 brain‑penetrant TKI, KRAS G12C+pembrolizumab, and lymphoma ADC/bispecific combo
18 May 2026
NRC Issues FONSI for Dow and X-energy Long Mott Nuclear Project in Texas
NRC completed an Environmental Assessment and issued a FONSI for a proposed advanced SMR at Seadrift, Texas, clearing a key Construction Permit step to supply electricity and industrial steam.
18 May 2026
SkyKraft awarded €21m Industriklivet grant for eSAF production in Skellefteå
Funding will cover feasibility, design and engineering toward FID in 2027 for an eSAF plant targeting 130,000 t/yr using renewable power and biogenic CO₂, signaling market confidence.
18 May 2026
Aramco and Pasqal launch Saudi Arabia’s first quantum computer and the Middle East’s first QCaaS platform
Located in Dhahran, a 200-qubit neutral-atom QPU offers low-latency cloud access for industrial apps, enabling optimization, simulation and AI for energy, materials, logistics, CO2 storage; workforce training.
18 May 2026
BASF opens refinery catalyst R&D center in Attapulgus, GA
R&D center focuses on applied FCC testing, QA/QC and scale-up at production site to speed commercialization and tailor catalyst solutions to refiners
18 May 2026
Essar Energy Transition completes Pre‑FEED for Stanlow Methanol‑to‑Jet SAF hub
Planned plant will convert ~550,000 tpa renewable methanol into >200,000 tpa jet fuel, using existing refinery blending and pipeline export; FEED this year, FID by early 2028.
18 May 2026
Merck: sac‑TMT meets OS and PFS endpoints in Phase 3 TroFuse‑005 for advanced/recurrent endometrial cancer
TroFuse‑005 (776 pts) showed significant OS and PFS improvement vs chemotherapy in advanced/recurrent endometrial cancer after platinum and anti‑PD‑1/PD‑L1 therapy; ORR met; safety consistent.
18 May 2026
Repsol and Santos begin Pikka oil production in Alaska
Partners reached first oil at a North Slope project; production to hit 80,000 bpd plateau in Q3 with first sales then. 28 wells drilled in phase 1; 45 wells planned; further phases expected.
18 May 2026
OMV starts production at Austria’s largest gas discovery in 40 years
Wittau well begins gas output; first phase 11 TWh for winter 2026/27, recoverable up to 48 TWh. EUR150m invested so far; project could double Austria’s gas production.
18 May 2026
Asahi Kasei Therapeutics starts Phase III trial of Teribone (teriparatide) for high‑risk osteoporosis
Domestic Phase III trial to assess extended therapy beyond 24 months for patients with severe osteoporosis at high fracture risk; evaluates efficacy and safety of continued treatment.
18 May 2026
Teijin Frontier and Asahi Kasei Advance form TA Frontier
Merged firm launches Oct 1, 2026; ownership split 80/20. It combines materials technologies and marketing across textiles, industrial, building and resins for sustainable growth.
18 May 2026
Chugai’s Alecensa Gets World-First Tumor‑Agnostic Approval for ALK‑Positive Solid Tumors
Japan approves tumor‑agnostic ALK inhibitor for ALK‑fusion solid tumors including pediatrics. TACKLE Phase II showed 70–76% response in ALK‑fusion cases; safety consistent. FoundationOne CDx approved.
18 May 2026
Chugai: MHLW approves FoundationOne CDx as Alecensa companion diagnostic for ALK‑positive solid tumors
TACKLE Phase II supported Alecensa's efficacy/safety, enabling a partial marketing-authorization change; FoundationOne CDx expands tumor-agnostic genomic profiling and treatment options.
18 May 2026
GSK’s Arexvy gains expanded approval in Japan for at‑risk adults 18–59
Approval now explicitly includes immunocompromised adults; Phase IIIb showed non‑inferior immune response versus older adults and a safety profile consistent with prior trials.
15 May 2026
PTT Global Chemical Q1 2026 Results: Integrated Value Chain Secures Production and Balances Portfolio
Q1 revenue THB 146,936m; net profit THB 3,232m. Operations sustained via feedstock flexibility and supply‑chain continuity. Pivoting to specialty chemicals, bioplastics and recycled plastics.
15 May 2026
Ercros Q1 2026: €13.6m loss
Q1: contribution €52m; adj. EBITDA −€1m; liquidity €45m. Weak demand, high energy costs, non‑EU competition. Bondalti bid 77.23% accepted. New board aims to delist, restore profitability, integrate
15 May 2026
Iberdrola completes phase 1 of Noronha Verde, installs 4,800 solar panels
Project pairs solar with battery storage on Fernando de Noronha to reach 22 MWp/49 MWh, replace biodiesel, supply ~9,000 homes; €50M (R$350M) investment, completion by end-2026.
15 May 2026
Genentech’s Tecentriq approved by FDA as ctDNA‑guided adjuvant therapy for MIBC
FDA approves first ctDNA‑MRD‑guided adjuvant option for muscle‑invasive bladder cancer. IMvigor011: ctDNA+ patients had 36% reduced DFS risk and 41% reduced OS risk; Signatera CDx authorized.
← Previous
Next →
